NATCO drug gets Canadian approval
Hyderabad, Jan 11: City-based NATCO Pharma Limited today announced that the Canadian Regulatory Agency (TPD Health Canada) had approved its Ondansetron 4 mg and 8 mg tablets.
The approval, accorded to its Canada-based marketing partner IP Generics, will facilitate NATCO to market its products in that country, according to a release here today. The TPD-Health Canada had already approved the Citalopram Hydrobromide 20 mg and 40 mg tablets of NATCO earlier, it added.
UNI
Comments
Story first published: Friday, January 11, 2008, 17:45 [IST]